Two Sigma Investments, LP Palisade Bio, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.11 - $83.85 $8,837 - $6.74 Million
80,338 New
80,338 $8,000
Q2 2022

Aug 15, 2022
SELL
$0.41 - $1.04 $8,839 - $22,422
-21,560 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.81 - $1.51 $5,737 - $10,695
7,083 Added 48.93%
21,560 $23,000
Q4 2021

Feb 14, 2022
BUY
$1.3 - $2.96 $18,820 - $42,851
14,477 New
14,477 $19,000

About PALISADE BIO, INC.

PALI Quotes by TradingView
  • Ticker PALI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,240,200
  • Market Cap $122M
  • Description
  • Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...
More about PALI
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email